JRI - Nuveen Real Asset Income and Growth Fund

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
Total Revenue
48,927
-49,513
34,373
Cost of Revenue
-
-
-
Gross Profit
-
-
-
Operating Expenses
Research Development
-
-
-
Selling General and Administrative
819
957
724
Total Operating Expenses
2,122
2,213
725
Operating Income or Loss
-
-
-
Interest Expense
6,661
6,108
2,411
Total Other Income/Expenses Net
-
-
-
Income Before Tax
46,806
-51,726
33,481
Income Tax Expense
-
-
-
Income from Continuing Operations
46,806
-51,726
33,481
Net Income
46,806
-51,726
33,481
Net Income available to common shareholders
46,806
-51,726
33,481
Reported EPS
Basic
-
-1.88
2.80
Diluted
-
-1.88
2.80
Weighted average shares outstanding
Basic
-
27,514
27,633
Diluted
-
27,514
27,633
EBITDA
-
-
-